Kelten Talu Canan, Yeni Erdem Begum, Arslan Esra, Nazli Mehmet Ali, Cakir Yasemin, Can Trabulus Didem
Department of Pathology, Izmir Faculty of Medicine, University of Health Sciences, Izmir, Turkey.
Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Eur J Breast Health. 2022 Oct 1;18(4):360-370. doi: 10.4274/ejbh.galenos.2022.2022-7-4. eCollection 2022 Oct.
Invasive papillary carcinoma (IPC) of the breast is an uncommon histologic subtype with limited data in the literature. The aim of this study was to increase the evidence base by presenting clinicopathological findings of cases diagnosed as IPC.
Hematoxylin and eosin sections and immunostaining of surgical excision specimens diagnosed as invasive breast carcinoma were re-evaluated, retrospectively.
IPC was detected in 22 cases (1.9%), of which 7 (0.6%) had pure and 15 (1.3%) had mixed morphology. Histologic types accompanying IPC were: Invasive ductal carcinoma (IDC) (15/15); invasive micropapillary carcinoma (3/15); and pleomorphic lobular carcinoma (1/15). Patient ages ranged between 36 and 89 (median 56.5) and the tumor size from 8 to 70 mm (median 19 mm). The histologic grade was 3 in five cases, 2 in 13, and 1 in four cases. The nuclear grade was 3 in 10 cases and 2 in 12. The values of positivity for estrogen receptor, progesterone receptor, human epidermal growth factor receptor-2, and Ki-67 index indicated Luminal B phenotype in 16 (72.7%), triple-negative in 5 (22.7%), and Luminal A in 1 case (4.6%). Ductal carcinoma was noted in 19 cases (86.4%).
IPC was mostly detected as an accompanying carcinoma to IDC at postmenopausal ages and was mostly Luminal B phenotype with intermediate-to-high grade features.
乳腺浸润性乳头状癌(IPC)是一种罕见的组织学亚型,文献中的相关数据有限。本研究的目的是通过呈现诊断为IPC的病例的临床病理特征来增加证据基础。
对诊断为浸润性乳腺癌的手术切除标本的苏木精-伊红切片和免疫染色进行回顾性重新评估。
共检测到22例IPC(1.9%),其中7例(0.6%)为纯形态,15例(1.3%)为混合形态。与IPC伴发的组织学类型有:浸润性导管癌(IDC)(15/15);浸润性微乳头状癌(3/15);多形性小叶癌(1/15)。患者年龄在36至89岁之间(中位年龄56.5岁),肿瘤大小为8至70毫米(中位大小19毫米)。组织学分级3级的有5例,2级的有13例,1级的有4例。核分级3级的有10例,2级的有12例。雌激素受体、孕激素受体、人表皮生长因子受体-2的阳性值以及Ki-67指数显示,16例(72.7%)为Luminal B型,5例(22.7%)为三阴性,1例(4.6%)为Luminal A型。19例(86.4%)可见导管癌成分。
IPC大多在绝经后年龄被检测为IDC的伴发癌,且大多为具有中高级别特征的Luminal B型。